Comparison of Recovery From General Anesthesia in Remimazolam With Flumazenil vs. Propofol

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

August 2, 2022

Primary Completion Date

December 21, 2022

Study Completion Date

December 21, 2022

Conditions
Recovery
Interventions
DRUG

REMIMAZOLAM BESYLATE 2.5 Mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, for SOLUTION [BYFAVO]

Remimazolam Besylate is used as an intervention drug for general anesthesia, followed by flumazenil administration at the end of anesthesia, compared to propofol-based total intravenous anesthesia during breast cancer surgery under general anesthesia

DRUG

Flumazenil

Flumazenil is used as an additional intervention drug to facilitate emergence from general anesthesia in the Remimazolam with Flumazenil group.

DRUG

Propofol

Propofol is used as an active comparator drug for general anesthesia until the end of anesthesia, to be compared to remimazolam besylate during breast cancer surgery under general anesthesia.

Trial Locations (1)

03080

Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER